ĢƵ

close

TAGGED : health

Aura Biosciences to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Nov 8, 2023--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, ...

Silence Therapeutics to Present at Jefferies London Healthcare Conference

LONDON--(BUSINESS WIRE)--Nov 8, 2023--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming peopleĢƵ lives by silencing diseases through precision engineered medicines, today announced that ...